+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios



Impact of Branched-Chain Amino Acid Granule Therapy in Patients with Hepatocellular Carcinoma Who Have Normal Albumin Levels and Low Branched-Chain Amino Acid to Tyrosine Ratios



Nutrition and Cancer 71(7): 1132-1141



Serum albumin has been reported to be a useful indicator of liver function and branched-chain amino acid (BCAA) therapy is associated with a lower incidence of hepatocellular carcinoma (HCC). We investigated the impact of BCAA granule therapy on overall survival and disease-specific survival in patients with normal albumin levels and low BCAA to tyrosine ratio (BTR)s who had treatment-naïve HCC. Overall survival and disease-specific survival was analyzed in 78 patients with HCC who were treated (n = 27) or not treated (n = 51) with BCAAs. Twenty-six patients died during the follow-up period. There were 19, 5, and 2 patients who died due to HCC, hepatic failure, and non-liver-related disease, respectively. Multivariate analysis for factors associated with overall survival indicated that BCAA therapy was independently associated with good prognosis in patients with HCC (hazard ratio [HR], 0.317; 95% confidence interval [CI], 0.123-0.813; P = 0.017). In addition, multivariate analysis using competing risks methods indicated that BCAA therapy is independently associated with reduction of disease-specific mortality (HR, 0.216; 95% CI, 0.068-0.689; P = 0.001). In conclusion, BCAA therapy improved both overall survival and disease-specific survival in HCC patients with low BTRs despite having normal albumin levels.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066664323

Download citation: RISBibTeXText

PMID: 30955354

DOI: 10.1080/01635581.2019.1597905


Related references

Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis. Journal of Gastroenterology and Hepatology 30(9): 1412-1419, 2015

Effect of branched-chain amino acid granules on 99mTc-GSA liver scintigraphy and branched-chain amino acid tyrosine mole ratio in cirrhotic patients. Gastroenterology 118(4 Suppl 2 Part 2): AASLD A148, 2000

Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. Journal of Gastrointestinal Surgery 15(8): 1433-1439, 2011

Mechanism of decreases in blood branched chain amino acid levels in liver cirrhosis 3. effects of administration of short chain fatty acid on blood branched chain amino acid concentrations in rats. Acta Scholae Medicinalis Universitatis in Gifu 29(4): 642-651, 1981

Divergent Induction of Branched-Chain Aminotransferases and Phosphorylation of Branched Chain Keto-Acid Dehydrogenase Is a Potential Mechanism Coupling Branched-Chain Keto-Acid-Mediated-Astrocyte Activation to Branched-Chain Amino Acid Depletion-Mediated Cognitive Deficit after Traumatic Brain Injury. Journal of Neurotrauma 35(20): 2482-2494, 2018

Mechanism of decreases in blood branched chain amino acid levels in liver cirrhosis 2. effects of administration of ammonia on blood branched chain amino acid concentrations in rats. Acta Scholae Medicinalis Universitatis in Gifu 29(4): 630-641, 1981

Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma. Hepatology Research 44(2): 149-158, 2014

Impact of branched-chain amino acid supplementation on survival in patients with advanced hepatocellular carcinoma treated with sorafenib: A multicenter retrospective cohort study. Hepatology Research 46(10): 1002-1010, 2016

Branched-chain ketoacid dehydrogenase activity and growth of normal and mutant human fibroblasts: the effect of branched-chain amino acid concentration in culture medium. Biochemical Genetics 21(9-10): 895-905, 1983

Regulation of taste-active components of meat by dietary branched-chain amino acids; effects of branched-chain amino acid antagonism. British Poultry Science 49(3): 299-307, 2008

Octanoic acid promotes branched-chain amino acid catabolisms via the inhibition of hepatic branched-chain alpha-keto acid dehydrogenase kinase in rats. Metabolism: Clinical and Experimental 64(9): 1157-1164, 2015

Clinical significance of early interventional therapy of branched-chain amino acid granules in patients with hepatocellular carcinoma: propensity score matching analysis. International Journal of Oncology 45(3): 1082-1090, 2014

Regulation of branched-chain amino acid metabolism and pharmacological effects of branched-chain amino acids. Hepatology Research 30s: 3-8, 2004

Efficiency of amino acid utilization in the growing pig at suboptimal levels of intake: branched-chain amino acids, histidine and phenylalanine + tyrosine. Journal of Animal Physiology and Animal Nutrition 87(1-2): 52-65, 2003

Regulation of branched-chain amino acid catabolism Interaction between branched-chain alpha -keto acid dehydrogenase complex and BCKDH kinase. FASEB Journal 18(4-5): Abst 372 9, 2004